Discover your next big idea for life sciences at PACK EXPO Las Vegas
Experience a breakthrough in life sciences packaging—explore solutions from 2,300 suppliers spanning all industries, all in one place this September

University of Michigan Creates EpiPen for Spine Injuries

Injecting nanoparticles into the spine can dampen the body’s immune response to spinal cord injuries and prevent paralysis.

Spine Injury / Image: Michigan Engineering
Spine Injury / Image: Michigan Engineering

A recent Michigan News article discussed a new development from University of Michigan that people are calling the “EpiPen for spinal cord injuries.” When trauma occurs in the body, an immune response sends cells to the damaged area to clear debris and begin the regenerative process. However, the central nervous system contains a blood-brain barrier that prevents immune activity from infiltrating the damaged area. A spinal cord injury breaks that barrier, resulting in immune cells flooding the area and creating too much inflammation. This damages the neurons and forms scars that prevent regeneration of nerve cells, leading to paralysis and loss of sensation.

To combat this, researchers at University of Michigan have created nanoparticles that intercept immune cells on their way to the spinal cord and prevent them from reaching the injury. The cells that do reach the spinal cord are altered to be more pro-regenerative. Fewer immune cells at the site of trauma means less inflammation and tissue deterioration, which gives the body a chance to heal and resume normal function.

Break out of the ordinary: see what’s new in life sciences packaging
<strong>At PACK EXPO Las Vegas, you’ll see machinery in action and new tech from 2,300 suppliers, collaborate with experts and explore transformative solutions. Join us in September to experience a breakthrough for life sciences products.</strong>
REGISTER NOW & SAVE!
Break out of the ordinary: see what’s new in life sciences packaging
FDA warning letters surge - is your team prepared?
New guide reveals expert strategies to prevent regulatory issues and respond effectively to FDA enforcement actions in pharmaceutical and medical device manufacturing.
Read More
FDA warning letters surge - is your team prepared?